Qi, Jie
Shi, Yue
Tan, Yezhen
Zhang, Qi
Zhang, Jianye
Wang, Jilu
Huang, Cong
Ci, Weimin
Funding for this research was provided by:
the National Natural Science Foundation of China (82173061)
the National Key R&D Program of China (2018YFC2000100)
the CAS Strategic Priority Research Program (XDA16010102)
Article History
Received: 20 May 2022
Accepted: 9 September 2022
First Online: 20 September 2022
Declarations
:
: All procedures involving mice and experimental protocols were approved by the University Institutional Animal Care and Use Committee (IACUC). This study has been approved by the ethics committees of the Peking University First Hospital. All samples and records were de-identified and anonymized prior to the study. Consent was obtained from all individuals for publication. No individual-level data are reported.
: All authors give consent for the publication of the manuscript in Molecular Cancer.
: The authors declare no competing interests.